Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Annual Meeting of Shareholders held earlier today was convened and adjourned without any business being conducted other than the adjournment due to a lack of quorum. The Company is just 1.1% of the outstanding shares of common stock shy of being able to conduct business and urges all of its shareholders to vote their shares over the weekend.
The meeting will reconvene this Monday, December 3, 2018 at 9:00 a.m. PT on the Internet through a virtual webcast at the same URL as provided previously. The record date for shareholders entitled to vote at the meeting will remain November 12, 2018. Shareholders can vote all weekend online as provided in the proxy materials sent previously.
The matters to be voted on at the meeting are unchanged and are still as set forth in the Notice of Meeting and Proxy Statement previously sent to its shareholders.
Shareholders of record that have not received notice of the annual meeting are encouraged to contact Investor Relations at email@example.com with the following information so that the company can attempt to verify your eligibility: holder name, number of shares held, address of record and name of brokerage firm in which your shares are held (if applicable).
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT:Public Relations Contact:Andrew HardChief Executive Officer CMW MediaP. 888-829- firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-announces-adjournment-of-virtual-annual-meeting-to-solicit-additional-votes-meeting-to-be-re-convened-monday-300758533.html
SOURCE Medical Marijuana, Inc.